The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

Discovery and development of bacteriophage for phage therapy

This collaborative research project is isolating clinically effective ‘cocktails’ of bacteriophages that kill bacteria resistant to antimicrobials.

Lead organisation(s):

Monash University. University of California in San Diego.

Project type:
Research
Status:
In progress
Description:

The project involves the Centre to Impact AMR, Monash University, working with clinicians from:

  • Alfred Hospital, Melbourne
  • the Center for Innovative Phage Applications & Therapeutics (University of California, San Diego – UCSD).

Isolating clinically effective ‘cocktails’ is a challenge that can only be met by collaboration between:

  • research scientists trained in phage biology (Monash)
  • phage manufacturing and formulation (Monash)
  • clinicians with experience in clinical deployment of phages (UCSD).
Timeframe:
The project was inititated this year, to run for 5 years.
For more information on this research or activity:

Edits to this research are currently being reviewed. If you want to update or request removal please email amr.website@health.gov.au.

Last updated:

Help us improve our website

If you would like a response please use the Feedback form instead.